CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $828,142 | -46.1% | 137,794 | -47.8% | 0.01% | -44.4% |
| Q3 2022 | $1,536,000 | +303.1% | 263,956 | +313.6% | 0.01% | +350.0% |
| Q2 2022 | $381,000 | -84.7% | 63,823 | -88.0% | 0.00% | -90.5% |
| Q1 2022 | $2,483,000 | +4498.1% | 531,600 | +2820.4% | 0.02% | +2000.0% |
| Q3 2021 | $54,000 | -57.8% | 18,203 | -64.5% | 0.00% | 0.0% |
| Q2 2021 | $128,000 | +75.3% | 51,287 | +105.0% | 0.00% | 0.0% |
| Q1 2021 | $73,000 | – | 25,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,000,000 | $3,881,000 | 2.23% |
| BVF INC/IL | 6,929,690 | $6,723,000 | 0.75% |
| CAXTON CORP | 323,026 | $313,000 | 0.29% |
| NEA Management Company, LLC | 3,750,000 | $3,638,000 | 0.19% |
| Orbimed Advisors | 5,000,000 | $4,851,000 | 0.08% |
| Fosun International Ltd | 300,428 | $288,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 105,385 | $102,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,055 | $29,000 | 0.00% |
| Renaissance Technologies | 1,282,352 | $1,244,000 | 0.00% |
| WASHINGTON TRUST Co | 16,000 | $15,000 | 0.00% |